Hologic Inc. ($HOLX) Stock Forecast: Down 8.5% Today

What is Hologic Inc.?

Hologic (HOLX) is a company specializing in medical technologies, primarily focusing on women's health. The stock is known for its innovations in diagnostics, imaging, and surgical products.

Why is Hologic Inc. going down?

HOLX stock is down 8.5% on May 2, 2025 13:36

• Despite Hologic (HOLX) delivering a strong earnings and revenue beat in the second quarter of fiscal 2025, the stock experienced a bearish movement.
• The lowering of the EPS view for the future might have dampened investor sentiment, leading to the negative market reaction.
• The market could be reacting to macroeconomic turbulence, which might be impacting the overall sentiment towards the stock.
• Investors might be concerned about the potential impact of the lowered EPS view and the uncertainties in the macroeconomic environment, leading to the bearish movement in HOLX.

HOLX Price Chart

HOLX Technical Analysis

HOLX News

Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down

HOLX delivers earnings and revenue beat in the second quarter of fiscal 2025 amid macroeconomic turbulence.

https://www.zacks.com/stock/news/2460932/hologic-q2-earnings-revenues-top-25-eps-view-lowered-stock-down

Hologic ( HOLX ) Tops Q2 Earnings and Revenue Estimates

Hologic (HOLX) delivered earnings and revenue surprises of 0.98% and 0.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2460582/hologic-holx-tops-q2-earnings-and-revenue-estimates

Insights Into Hologic ( HOLX ) Q2: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Hologic (HOLX) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

https://www.zacks.com/stock/news/2456699/insights-into-hologic-holx-q2-wall-street-projections-for-key-metrics

GYN Surgical Division Likely to Drive Hologic's Q2 Earnings

HOLX's second-quarter fiscal 2025 performance is likely to have benefited from expanding breast health offerings.

https://www.zacks.com/stock/news/2456565/gyn-surgical-division-likely-to-drive-hologics-q2-earnings

Trending Today

Movement ($MOVE) Crypto Forecast: Up 7.0% Today

Bitcoin Cash ($BCH) Crypto Forecast: Up 5.0% Today

Immutable ($IMX) Crypto Forecast: Up 10.4% Today

Ethena ($ENA) Crypto Forecast: Down 5.2% Today

Sui ($SUI) Crypto Forecast: Down 5.6% Today

Natural Gas ($GAS) Commodity Forecast: Up 5.9% Today

Sirius XM Holdings Inc. ($SIRI) Stock Forecast: Up 5.1% Today

Affirm Holdings Inc. ($AFRM) Stock Forecast: Up 5.0% Today

Memecoin ($MEME) Crypto Forecast: Down 5.4% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Up 5.1% Today

Hologic Inc. Price History

17.09.2024 - HOLX Stock was down 1.9%

• Concerns have arisen among investors due to the $350 million acquisition of Gynesonics and its potential short-term financial impact on Hologic.
• The market's response to this acquisition suggests a perception of heightened competition within the women's health industry, prompting a sell-off of HOLX shares.
• Investor caution regarding the integration of Gynesonics' Sonata System into Hologic's product lineup is fostering uncertainty and contributing to a downward trend in the stock price.

10.10.2023 - HOLX Stock was up 5.5%

• The bullish movement in HOLX today can be attributed to the following factors:
• 1. Strong Q4 Performance: Hologic Inc. reported better than expected Q4 results, with solid year-over-year growth in the Breast Health segment. This positive performance likely contributed to the bullish movement in the stock.
• 2. Earnings Beat Estimates: Despite a decrease in Q4 profit compared to the same period last year, Hologic Inc. managed to beat Street estimates. This positive surprise may have boosted investor confidence and led to the bullish market movement.
• 3. Investor Sentiment: The stock gained 2% on the back of the better than expected Q4 results. This indicates that investors have reacted positively to the company's performance, further driving the bullish movement.
• Overall, Hologic Inc.'s strong Q4 performance and ability to beat earnings estimates likely fueled the bullish market movement in HOLX today.

10.11.2024 - HOLX Stock was up 2.1%

• An analyst recently initiated coverage on Hologic, Inc. with an optimistic outlook, potentially influencing investor sentiment and interest in the stock.
• Although there has been a slight decrease in the stock price post their last earnings report, investors seem hopeful for a recovery based on favorable analyst coverage and growth prospects in the medical technologies industry.
• The positive movement in HOLX today may be attributed to growing investor confidence, spurred by favorable analyst assessments and expectations of a potential stock price revival following the recent earnings report.

14.09.2024 - HOLX Stock was up 1.6%

• Hologic (HOLX) is likely experiencing a bullish trend due to its impressive earnings surprise history and the anticipation of beating estimates in its next quarterly performance.
• The company's new campaign for Breast Cancer Awareness Month may have also contributed to positive market sentiment, attracting investors who are optimistic about its performance and potential growth in the women's health sector.
• The combination of strong fundamentals, positive market sentiment, and strategic initiatives like the awareness campaign could be driving the bullish movement in HOLX stock today.

05.10.2024 - HOLX Stock was down 5.6%

• HOLX stock experienced a bearish movement due to Q4 earnings missing estimates by -0.98%.
• The disappointing financial results may have led to a lack of investor confidence and a subsequent sell-off of the stock.
• Investors had higher expectations for Hologic's performance, leading to concerns about future growth prospects.
• A closer examination of key metrics beyond traditional estimates could provide insights into areas of underperformance, prompting investors to reassess the stock's potential.

06.01.2025 - HOLX Stock was down 7.4%

• HOLX performed well in Q1 but issued a bleak sales forecast for 2025, resulting in a pessimistic market outlook.
• The stock price was affected as investors responded unfavorably to the lower sales projection for 2025.
• Despite strong Q1 earnings, the market predominantly reacted to the future sales guidance, causing a decline in the stock value.
• Investors' focus on forward-looking guidance over historical performance was evident in the market's response.

08.03.2025 - HOLX Stock was down 4.2%

• The addition of new leadership at Hologic may have initially been seen as a positive move, indicating potential stability and growth for the company.
• However, the mention of ongoing global uncertainties could have spooked investors, leading to a bearish movement in the stock.
• Investors may be cautious due to the uncertain global economic outlook, causing them to reevaluate their positions in HOLX despite its strong diagnostics strength and international potential.

02.04.2025 - HOLX Stock was down 8.5%

• Despite Hologic (HOLX) delivering a strong earnings and revenue beat in the second quarter of fiscal 2025, the stock experienced a bearish movement.
• The lowering of the EPS view for the future might have dampened investor sentiment, leading to the negative market reaction.
• The market could be reacting to macroeconomic turbulence, which might be impacting the overall sentiment towards the stock.
• Investors might be concerned about the potential impact of the lowered EPS view and the uncertainties in the macroeconomic environment, leading to the bearish movement in HOLX.